National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meetings, 8289-8290 [2018-03780]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 38 / Monday, February 26, 2018 / Notices
FOR FURTHER INFORMATION CONTACT:
Anyone requesting information
regarding the ACCV should contact
Annie Herzog, Program Analyst,
Division of Injury Compensation
Programs (DICP), HRSA in one of three
ways: (1) Send a request to the following
address: Annie Herzog, Program
Analyst, DICP, HRSA, 5600 Fishers
Lane, 08N146B, Rockville, Maryland
20857; (2) call (301) 443–6593; or (3)
send an email to aherzog@hrsa.gov.
The ACCV will meet on Thursday,
March 8, 2018, beginning at 10:00 a.m.
via Adobe Connect Meeting; however,
meeting times and information to join
the meeting and/or conference call
could change. For the latest information
regarding meeting start time and
information to join the meeting and/or
conference call, please check the ACCV
website: https://www.hrsa.gov/
advisorycommittees/childhoodvaccines/
index.html.
The ACCV
was established by section 2119 of the
Public Health Service Act (the Act) (42
U.S.C. 300aa–19), as enacted by Public
Law (Pub. L.) 99–660, and as
subsequently amended, and advises the
Secretary of HHS (the Secretary) on
issues related to implementation of the
National Vaccine Injury Compensation
Program (VICP).
Other activities of the ACCV include:
Recommending changes to the Vaccine
Injury Table at its own initiative or as
the result of the filing of a petition;
advising the Secretary in implementing
section 2127 of the Act regarding the
need for childhood vaccination
products that result in fewer or no
significant adverse reactions; surveying
federal, state, and local programs and
activities related to gathering
information on injuries associated with
the administration of childhood
vaccines, including the adverse reaction
reporting requirements of section
2125(b) of the Act; advising the
Secretary on the methods of obtaining,
compiling, publishing, and using
credible data related to the frequency
and severity of adverse reactions
associated with childhood vaccines;
consulting on the development or
revision of Vaccine Information
Statements; and, recommending to the
Director of the National Vaccine
Program research related to vaccine
injuries which should be conducted to
carry out the VICP.
The agenda items for the March 8,
2018, meeting will include, but are not
limited to, updates from DICP,
Department of Justice (DOJ), National
Vaccine Program Office (NVPO),
Immunization Safety Office (Centers for
daltland on DSKBBV9HB2PROD with NOTICES
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
17:58 Feb 23, 2018
Jkt 244001
Disease Control and Prevention),
National Institute of Allergy and
Infectious Diseases (National Institutes
of Health) and Center for Biologics,
Evaluation and Research (Food and
Drug Administration). A draft agenda
and additional meeting materials will be
posted on the ACCV website: https://
www.hrsa.gov/advisorycommittees/
childhoodvaccines/ prior to
the meeting. Agenda items are subject to
change as priorities dictate.
Members of the public will have the
opportunity to provide comments. Oral
comments will be honored in the order
they are requested and may be limited
as time allows. Requests to make oral
comments or provide written comments
to the ACCV should be sent to Annie
Herzog by March 5, 2018, using the
address and phone number above.
Individuals who plan to participate and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify Annie Herzog, using the address
and phone number above at least 10
days prior to the meeting.
Amy McNulty,
Acting Director, Division of the Executive
Secretariat.
[FR Doc. 2018–03812 Filed 2–23–18; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel; NIAAA Member Conflict
Applications.
Date: March 27, 2018.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
8289
Place: National Institutes of Health,
National Institute on Alcohol Abuse and
Alcoholism, 5635 Fishers Lane Bethesda, MD
20892 (Telephone Conference Call).
Contact Person: Ranga Srinivas, Ph.D.,
Chief, Extramural Project Review Branch,
National Institute on Alcohol Abuse and
Alcoholism, National Institutes of Health,
5365 Fishers Lane, Room 2085, Rockville,
MD 20852, (301) 451–2067, srinivar@
mail.nih.gov.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel; NIAAA Member Conflict
Applications—AA3.
Date: April 2, 2018.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Alcohol Abuse and
Alcoholism, 5635 Fishers Lane, Bethesda,
MD 20892 (Telephone Conference Call).
Contact Person: Ranga Srinivas, Ph.D.,
Chief, Extramural Project Review Branch,
National Institute on Alcohol Abuse and
Alcoholism, National Institutes of Health,
5365 Fishers Lane, Room 2085, Rockville,
MD 20852, (301) 451–2067, srinivar@
mail.nih.gov.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Initial
Review Group; Epidemiology, Prevention
and Behavior Research Review
Subcommittee.
Date: June 4, 2018.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Alcohol Abuse and
Alcoholism, 5635 Fishers Lane, Terrace Level
Conference Room 508, Bethesda, MD 20892.
Contact Person: Anna Ghambaryan, M.D.,
Ph.D., Scientific Review Officer, Extramural
Project Review Branch, National Institute on
Alcohol Abuse and Alcoholism, National
Institutes of Health, 5365 Fishers Lane, Room
2019, Rockville, MD 20852, (301) 443–4032,
anna.ghambaryan@nih.gov.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Initial
Review Group; Clinical, Treatment and
Health Services Research Review
Subcommittee.
Date: June 15, 2018.
Time: 8:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn San Diego Bayside,
4875 North Harbor Drive, San Diego, CA
92106.
Contact Person: Ranga Srinivas, Ph.D.,
Chief, Extramural Project Review Branch,
National Institute on Alcohol Abuse and
Alcoholism, National Institutes of Health,
5365 Fishers Lane, Room 2085, Rockville,
MD 20852, (301) 451–2067, srinivar@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
E:\FR\FM\26FEN1.SGM
26FEN1
8290
Federal Register / Vol. 83, No. 38 / Monday, February 26, 2018 / Notices
93.891, Alcohol Research Center Grants;
93.701, ARRA Related Biomedical Research
and Research Support Awards, National
Institutes of Health, HHS)
Dated: February 20, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–03780 Filed 2–23–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary
and Integrative Health; Notice of
Meeting
daltland on DSKBBV9HB2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Center for
Complementary and Integrative Health
Special Emphasis Panel.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Integrative Health
Special Emphasis Panel; Exploratory Clinical
Trials of Mind and Body Interventions
Review Panel.
Date: March 15, 2018.
Time: 12:00 p.m. to 5:15 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20852, (Virtual
Meeting).
Contact Person: Ashlee Tipton, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Center for
Complementary and Integrative Health, 6707
Democracy Boulevard, Room 401, Bethesda,
MD 20892, 301–451–3849, ashlee.tipton@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: February 20, 2018.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–03777 Filed 2–23–18; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
17:58 Feb 23, 2018
Jkt 244001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary
and Integrative Health; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Center for
Complementary and Integrative Health
Special Emphasis Panel.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Integrative Health
Special Emphasis Panel; NCCIH Natural
Product Phase I–IIa Clinical Trial Award.
Date: March 22, 2018.
Time: 12:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Viatcheslav A
Soldatenkov, MD, Ph.D., Scientific Review
Officer, Office of Scientific Review, Division
of Extramural Activities, NCCIH/NIH, 6707
Democracy Boulevard, Suite 401, Bethesda,
MD 20892, soldatenkovv@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Complementary and Integrative Health
Special Emphasis Panel.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Integrative Health
Special Emphasis Panel; Center of Excellence
for Research on Complementary and
Integrative Health (P01) Special Emphasis
Panel.
Date: March 23, 2018.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20852 (Video
Assisted Meeting).
Contact Person: Yisong Wang, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, Division of Extramural Activities,
National Center for Complementary &
Integrative Health (NCCIH), National
Institutes of Health, 6707 Democracy Blvd.,
Suite 401, Bethesda, MD 20817, 301–480–
9483, yisong.wang@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: February 20, 2018.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–03779 Filed 2–23–18; 8:45 am]
BILLING CODE 4140–01–P
Dated: February 20, 2018.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HOMELAND
SECURITY
[FR Doc. 2018–03778 Filed 2–23–18; 8:45 am]
[USCG–2017–0894]
BILLING CODE 4140–01–P
2016.1 National Preparedness for
Response Exercise Program (PREP)
Guidelines
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Center for Complementary
and Integrative Health; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Center for
Frm 00052
Fmt 4703
Sfmt 4703
Coast Guard, DHS.
Notice of availability and
request for comments.
AGENCY:
ACTION:
National Institutes of Health
PO 00000
Coast Guard
The U.S. Coast Guard solicits
public comment on the regulatory
analysis of the potential deregulatory
savings that may result from the
revisions proposed in the 2016.1 PREP
Guidelines. The Coast Guard also
continues to seek public comment on
SUMMARY:
E:\FR\FM\26FEN1.SGM
26FEN1
]]>Agencies
[Federal Register Volume 83, Number 38 (Monday, February 26, 2018)]
[Notices]
[Pages 8289-8290]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-03780]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse and Alcoholism; Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Alcohol Abuse and
Alcoholism Special Emphasis Panel; NIAAA Member Conflict
Applications.
Date: March 27, 2018.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute on
Alcohol Abuse and Alcoholism, 5635 Fishers Lane Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Ranga Srinivas, Ph.D., Chief, Extramural Project
Review Branch, National Institute on Alcohol Abuse and Alcoholism,
National Institutes of Health, 5365 Fishers Lane, Room 2085,
Rockville, MD 20852, (301) 451-2067, [email protected].
Name of Committee: National Institute on Alcohol Abuse and
Alcoholism Special Emphasis Panel; NIAAA Member Conflict
Applications--AA3.
Date: April 2, 2018.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute on
Alcohol Abuse and Alcoholism, 5635 Fishers Lane, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Ranga Srinivas, Ph.D., Chief, Extramural Project
Review Branch, National Institute on Alcohol Abuse and Alcoholism,
National Institutes of Health, 5365 Fishers Lane, Room 2085,
Rockville, MD 20852, (301) 451-2067, [email protected].
Name of Committee: National Institute on Alcohol Abuse and
Alcoholism Initial Review Group; Epidemiology, Prevention and
Behavior Research Review Subcommittee.
Date: June 4, 2018.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute on
Alcohol Abuse and Alcoholism, 5635 Fishers Lane, Terrace Level
Conference Room 508, Bethesda, MD 20892.
Contact Person: Anna Ghambaryan, M.D., Ph.D., Scientific Review
Officer, Extramural Project Review Branch, National Institute on
Alcohol Abuse and Alcoholism, National Institutes of Health, 5365
Fishers Lane, Room 2019, Rockville, MD 20852, (301) 443-4032,
[email protected].
Name of Committee: National Institute on Alcohol Abuse and
Alcoholism Initial Review Group; Clinical, Treatment and Health
Services Research Review Subcommittee.
Date: June 15, 2018.
Time: 8:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: Holiday Inn San Diego Bayside, 4875 North Harbor Drive,
San Diego, CA 92106.
Contact Person: Ranga Srinivas, Ph.D., Chief, Extramural Project
Review Branch, National Institute on Alcohol Abuse and Alcoholism,
National Institutes of Health, 5365 Fishers Lane, Room 2085,
Rockville, MD 20852, (301) 451-2067, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.271,
Alcohol Research Career Development Awards for Scientists and
Clinicians; 93.272, Alcohol National Research Service Awards for
Research Training; 93.273, Alcohol Research Programs;
[[Page 8290]]
93.891, Alcohol Research Center Grants; 93.701, ARRA Related
Biomedical Research and Research Support Awards, National Institutes
of Health, HHS)
Dated: February 20, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-03780 Filed 2-23-18; 8:45 am]
BILLING CODE 4140-01-P
